Officials proposed limiting the amount of nicotine to make cigarettes less addictive, but it's unclear if the incoming administration will offer support.

U.S. regulators are proposing to cap the amount of nicotine in cigarettes at non-addictive levels, in a potential world-first that could curb smoking and hit tobacco industry earnings. The U.S. Food and Drug Administration (FDA),

Altria Group stock outperformed the S&P 500 over the past year (total return), something you don't hear about so often. See why I upgrade my rating on MO to buy.

The Biden White House is expected to formally propose a plan ordering cigarette nicotine levels to be reduced dramatically.

A rather historic U.S. Food and Drug Administration (FDA) proposal aims to make cigarettes and other tobacco products far less addictive by reducing their nicotine content.

Despite the seemingly restrictive nature of the FDA's proposed ruling, I remain highly optimistic about the resilience and adaptability

Now it competes with or is similar to, among others: Altria posted better-than-expected third-quarter results as robust vape and nicotine pouch demand offset shrinking market share for the ...

Even if the effort goes ahead under Trump, tobacco companies like Reynolds American and Altria are almost certain ... and said Wednesday that reducing nicotine would help nearly 13 million current ...

Discover why Altria may be a strong investment opportunity, with potential for significant total returns and a possible credit rating upgrade. Explore more here.

Federal officials on Wednesday released a far-reaching proposal to make cigarettes far less addictive by capping their nicotine content, a goal long sought by antismoking advocates that

Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes. The Food and Drug Administration OK'd 10 Zyn flavors,